Similarly, siRNA delivery using polyethylenimide-coated mesoporous silica nanoparticles effectively silenced TWIST1 and inhibited CCL2 expression, thereby inhibiting tumor growth in an in vivo model. The gene discussed is CCL2; the disease is neoplasm.